Soil and Water Pollution Monitoring, Protection and Remediation

Soil and Water Pollution Monitoring, Protection and Remediation
Author: Irena Twardowska
Publisher: Springer Science & Business Media
Total Pages: 638
Release: 2007-04-30
Genre: Science
ISBN: 1402047282

This book details the state-of-the art in early warning monitoring of anthropogenic pollution of soil and water. It is unique with regard to its complex, multidisciplinary, mechanistic approach. Top scientists establish links and strengthen weak connections between specific fields in biology, microbiology, chemistry, biochemistry, toxicology, sensoristics, soil science and hydrogeology.

Wastewater Quality Monitoring and Treatment

Wastewater Quality Monitoring and Treatment
Author: Philippe Quevauviller
Publisher: John Wiley & Sons
Total Pages: 424
Release: 2006
Genre: Science
ISBN:

The issue of water quality monitoring is becoming a huge area as the EU requirements for cleaner water increase. On-line monitoring involves measuring a body of water constantly and in-situ as opposed to analysing samples in the lab. Currently filling the gap in the market, Wastewater Quality Monitoring: On-line Methods provides information on how to produce the best analyses of wastewater in order to meet the above mentioned requirements. This reference will prove invaluable to all local water companies, industrial companies producing wastewater, as well as environment agencies and researchers.

Hepatitis and Liver Cancer

Hepatitis and Liver Cancer
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 252
Release: 2010-04-23
Genre: Medical
ISBN: 0309153689

The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations.